The product should not be given intravenously
Key Features Blend strength: BPC-157 10 mg + TB-500 10 mg per vial (20 mg total) Pack size: 10 vials/kit (bulk supply available on request) Format: lyophilized powder for stable storage and handling in lab workflows Supplier positioning: China-based factory supply with export-ready cartons and secure packing Documentation: batch labeling and order coordination support for repeat wholesale buyers Typical Research Focuses Recovery-support and tissue-repair pathway models (non-clinical, research settings) Mobility & training-load recovery study frameworks (protocol-based, lab handling required) Stack compatibility research and stability handling for lyophilized peptide formats General peptide handling, storage, and logistics workflows for distributors Packaging & Ordering Standard inner packing: 10-vial plastic trays with bubble wrap and foam protection Outer packing: export-ready cartons with insulation and protective materials suitable for international transit Flexible order quantities starting from 1 kit for sample evaluation
The bacteria can then degrade the peptide itself, altering its structure and rendering it useless
5-Amino-1MQ protocols typically use 510mg daily, while BPC-157 uses 250500mcg and TB-500 uses 25mg weekly
Injection site reactions such as minor redness, transient swelling, or localized soreness are normal and usually resolve within 24 hours
Additionally, its sterile nature reduces the risk of infection, and its bacteriostatic function means that it can be used multiple times without losing potency
